Introduction

Molecular Medicine Reports

1791-2997 1791-3004

D.A. Spandidos

10.3892/mmr.2019.10267

mmr-20-01-0401

Articles

Crocin protects against dexamethasone-induced osteoblast apoptosis by inhibiting the ROS/Ca²⁺-mediated mitochondrial pathway

Nie

Zhigang

* Deng

Shuang

* Zhang

Lei

* Chen

Sen

Qiang

Peng

Hao

Department of Orthopedics, Renmin Hospital of Wuhan University, Wuhan, Hubei 430060, P.R. China

Correspondence to: Professor Hao Peng, Department of Orthopedics, Renmin Hospital of Wuhan University, 99 Zhangzhidong Road, Wuhan, Hubei 430060, P.R. China, E-mail: penghaowhu123@163.com *

Contributed equally

072019

22052019

20 1 401 408 01072018 28022019

2019

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.

Osteoblast apoptosis has been identified as an important event in the development of glucocorticoid (GC)-induced osteoporosis and osteonecrosis of the femoral head. Crocin, a bioactive ingredient of saffron, has been demonstrated to induce antiapoptotic effects on numerous types of cell in vitro; however, the effects of crocin on the dexamethasone (Dex)-induced apoptosis of osteoblasts remain unclear. In the present study, the protective effects of crocin during Dex-induced apoptosis of MC3T3-E1 osteoblasts, and the underlying mechanisms, were investigated. MTT and Annexin V-FITC/PI flow cytometry assays were performed to evaluate the viability and apoptosis of cells, respectively. The mitochondrial transmembrane potential, reactive oxygen species (ROS), intracellular Ca²⁺ levels and apoptosis-associated protein expression were assessed via flow cytometry, fluorescence microscopy and western blotting. It was demonstrated that crocin pretreatment inhibited Dex-induced apoptosis of osteoblasts in a dose-dependent manner. Crocin reversed Dex-induced decreases in the mitochondrial transmembrane potential, and increases in ROS and intracellular Ca²⁺ levels. Furthermore, crocin upregulated the expression levels of B-cell lymphoma-2 (Bcl-2) and mitochondrial cytochrome c (Cyt C), and downregulated those of cleaved caspase-9, cleaved caspase-3, Bcl-2-associated X protein and cytoplasmic Cyt C. N-acetylcysteine, a ROS inhibitor, and 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid, a calcium chelator, attenuated Dex-induced osteoblast apoptosis, whereas H₂O₂ and ionomycin, a calcium ionophore that increases intracellular calcium levels, reversed the antiapoptotic effects of crocin on Dex-treated osteoblasts. These results indicated that crocin may protect osteoblasts from Dex-induced apoptosis by inhibiting the ROS/Ca²⁺-mediated mitochondrial pathway, thus suggesting that crocin has potential value as a treatment for GC-induced bone diseases.

crocin osteoblast apoptosis mitochondrial pathway

Introduction

Glucocorticoids (GCs) are widely used as treatments for various diseases (1), including systemic lupus erythematosus, idiopathic thrombocytopenic purpura and nephrotic syndrome; however, GC use can lead to numerous complications, the most serious of which are osteoporosis and osteonecrosis of the femoral head (ONFH) (2). Osteoblast apoptosis is regarded as an important pathogenic mechanism underlying these two complications (3–6). Consistent with these findings, previous studies have detected a large number of TUNEL-positive osteoblasts (apoptotic cells) in the femoral head of GC-treated rats (7,8). Therefore, the development of novel treatments that inhibit osteoblast apoptosis is required.

The role of reactive oxygen species (ROS) in osteoblast apoptosis has received considerable attention from researchers. Dai et al (9) revealed that H₂O₂ induces apoptosis in the Saos-2 osteoblastic cell line, which is attenuated by curcumin via increased protein kinase B-glycogen synthase kinase 3β signaling and preservation of mitochondrial function. Additionally, Linares et al (10) confirmed that apoptosis is induced in MC3T3-E1 cells by H₂O₂ and revealed that the effect is regulated by glutaredoxin 5. Li et al (11) reported that aluminum induces osteoblast apoptosis via the oxidative stress-mediated c-Jun N-terminal kinase (JNK) pathway. ROS serve roles in promoting apoptosis by inducing cytochrome c (Cyt C) release from the mitochondria to the cytosol (12). Furthermore, ROS have been reported to induce apoptosis of osteoblasts via activation of a protein kinase Cβ/p66^shc/JNK signaling cascade (13). Intracellular Ca²⁺ is also involved in inducing apoptosis of various cell types (14,15); however, the role of Ca²⁺ in osteoblasts remains unclear. At present, only Nam et al (16) has reported that H₂O₂ increases intracellular Ca²⁺ levels in osteoblasts, subsequently inducing cell death.

Crocin (Fig. 1A) is a major bioactive component extracted from saffron, which has been reported to possess anticancer, anti-inflammatory, antioxidant and antiapoptotic properties (17–20). As revealed by Santhosh et al (21), crocin provides notable protection against Vipera russelli venom-induced oxidative stress and neutrophil apoptosis. Additionally, Oruc et al (22) reported that crocin exhibits antiapoptotic and antioxidant effects on ischemia-reperfusion injury induced by four-vessel occlusion. The effects of crocin on intracellular Ca²⁺ signaling have received limited attention, with the exception of a study by Liu et al (23), which revealed that crocin decreases the L-type Ca²⁺ current and inhibits Ca²⁺ entry into cardiomyocytes, thereby exerting cardioprotective effects. Notably, crocin has been demonstrated to protect against ovariectomy-induced osteoporosis by inhibiting oxidative stress in a rat model (24). Therefore, it has been suggested that crocin may serve a protective role in osteoblasts. This study hypothesized that crocin may suppress dexamethasone (Dex)-induced osteoblast apoptosis by inhibiting the ROS/Ca²⁺-mediated mitochondrial pathway.

In the present study, the effects of crocin on Dex-induced osteoblast apoptosis and its underlying mechanisms were investigated. ROS and intracellular Ca²⁺ levels, and the activity of the mitochondrial apoptotic pathway, were determined following crocin administration in Dex-treated MC3T3-E1 osteoblasts.

Materials and methods <sec> <title>Materials

Crocin (cat. no. 17304), MTT (cat. no. M2128), N-acetyl-L-cysteine (NAC, cat. no. A7250), 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA-AM; cat. no. 14510), H₂O₂ (cat. no. 88597), ionomycin (Ion; cat. no. 407952), and dimethyl sulfoxide (cat. no. 156914) were purchased from Sigma-Aldrich (Merck KGaA, Darmstadt, Germany). The purity of crocin was determined to be 98.06% via high-performance liquid chromatography conducted by the Department of Pharmacology of Wuhan University (Wuhan, China). Dex was acquired from Shanghai Aladdin Bio-Chem Technology Co., Ltd. (Shanghai, China, cat. no. D137736). An Annexin V-fluorescein isothiocyanate (FITC)/propidium iodide (PI) kit was purchased from Nanjing KeyGen Biotech Co., Ltd. (Nanjing, China; cat. no. KGA108). JC-1 Assay (cat. no. C2006), ROS Assay (cat. no. S0033), Mitochondria Isolation (cat. no. C3601), Bicinchoninic Acid (BCA; cat. no. P0010) Assay and Caspase-3 Activity Assay kits (cat. no. C1116), and phenylmethylsulfonyl fluoride (PMSF; cat. no. ST506) were acquired from Beyotime Institute of Biotechnology (Shanghai, China). A Fluo-3 AM kit was purchased from Dojindo Molecular Technologies, Inc. (Kumamoto, Japan; cat. no. F026). B-cell lymphoma-2 (Bcl-2; cat. no. 4223S), Bcl-2-associated X protein (Bax; cat. no. 2772T), cleaved caspase-3 (cat. no. 9664T), −8 (cat. no. 8592) and −9 (cat. no. 9509) antibodies were purchased from Cell Signaling Technology, Inc. (Danvers, MA, USA). Cyt C antibody was obtained from Wuhan Sanying Biotechnology (Wuhan, China; cat. no. 10993-1-AP). GAPDH antibody was acquired from Hangzhou Goodhere Biotechnology Co., Ltd. (Hangzhou, China; cat. no. AB-P-R 001). Cyt C oxidase IV (COX IV; cat. no. ab16056) antibody was purchased from Abcam (Cambridge, UK). Horseradish peroxidase-conjugated secondary antibodies were acquired from Boster Biological Technology (Pleasanton, CA, USA; cat. no. BA1054).

Cell culture

MC3T3-E1 osteoblasts were obtained from Wuhan Biofavor Biotech Services Co., Ltd. (Wuhan, China). Cells were cultured in α-minimal essential medium (Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 100 U/ml penicillin and 100 µg/ml streptomycin at 37°C in an atmosphere containing 5% CO₂.

Cell viability assay

Cells were cultured in 96-well plates at a density of 5×10³ cells/well. Increasing concentrations of crocin (0, 5, 25, 100, 400, 1,000 and 4,000 µM) were added to the wells, and cells were incubated at 37°C for 24 or 48 h. Then, nontoxic concentrations of crocin were determined using an MTT assay and were selected for subsequent experiments. Three concentrations (5, 25 and 100 µM) were then used to investigate the protective effects of crocin against 1 µM Dex-induced cytotoxicity using an MTT assay. Cells were pretreated with 5, 25 and 100 µM crocin for 1 h, and then treated with 1 µM Dex for a further 24 or 48 h. Cells were incubated at 37°C. The MTT assay was conducted as follows: Following aforementioned treatment and incubation, MTT reagent (10 µl) was added to wells, and the plates were incubated at 37°C for 4 h. The medium was then discarded, and 150 µl dimethyl sulfoxide was added to the wells to dissolve the formazan crystals. The absorbance was detected at 568 nm using a microplate reader (Thermo Fisher Scientific, Inc.).

Apoptosis assay

An Annexin V-FITC/PI assay was used to determine the apoptosis of osteoblasts. Cells were pretreated with 5, 25 and 100 µM crocin for 1 h, and then treated with 1 µM Dex for a further 24 h. Cells were incubated at 37°C. Following treatment, cells were washed twice with PBS, and were then incubated with 5 µl Annexin V and 5 µl PI in the dark at room temperature for 15 min. Subsequently, the cells were subjected to flow cytometry (Beckmancoulter, Brea, CA, USA), and CytExpert 2.0 software (Beckmancoulter) was used to determine the percentage of apoptotic cells. Annexin V⁺/PI⁻ cells were designated as early apoptotic cells, whereas Annexin V⁺/PI⁺ cells were identified as late apoptotic cells. The total percentage of apoptotic cells was calculated by adding the percentage of early apoptotic cells to the percentage of late apoptotic cells.

Effects of increase and decrease of ROS and Ca2+

NAC, H₂O_2, BAPTA-AM, and Ion were added to cells to observe the effects of increases and decreases in ROS and Ca²⁺ on the mitochondrial transmembrane potential (Δψm), caspase-3 activity, ROS levels, Ca²⁺ levels and apoptotic rate of osteoblasts. Cells were pretreated with 100 µM Cro, 2 mM NAC, 20 µM BAP, 100 µM H₂O₂ or 0.5 µM Ion for 1 h at 37°C prior to treatment with 1 µM Dex for 24 h at 37°C. The effects of NAC and BAP on Dex-induced mitochondrial membrane potential (Δψm) changes, caspase-3 activation, osteoblast apoptosis, and ROS and Ca²⁺ levels were evaluated. The effects of H₂O₂ and Ion on the protective effects of Cro against Dex-induced Δψm changes, caspase-3 activation, osteoblast apoptosis, and ROS and Ca²⁺ levels were also evaluated.

Measurement of the Δψm

The Δψm was measured using the JC-1 Assay kit, according to the manufacturer's protocol. Briefly, following treatment, cells were incubated with JC-1 solution (500 µl) at 37°C for 20 min and were then centrifuged at 13,500 × g for 3 min at 4°C. Subsequently, the cells were washed and resuspended in 1X incubation buffer (provided in the assay kit) three times. Finally, the Δψm was determined by flow cytometry. The JC-1 polymer/monomer fluorescence ratio was used to quantify the Δψm.

ROS detection

ROS levels were determined via two methods using the ROS Assay kit: Flow cytometry and fluorescence microscopy. Briefly, following treatment, cells were incubated with dichlorodihydrofluorescein diacetate solution (10 µM) at 37°C for 20 min. Cells were then washed three times with serum-free medium and washed twice with PBS. Finally, a flow cytometer was used to quantify the fluorescence intensity as a measure of ROS production, and data were analyzed using CytExpert 2.0 software. A fluorescence microscope (Olympus Corporation, Tokyo, Japan) and cellSens Entry 1.17 software (Olympus Corporation) was used to observe intracellular ROS fluorescence.

Intracellular Ca2+ detection

The Ca²⁺ dye Fluo-3 AM was used to determine intracellular Ca²⁺ levels. Two methods, flow cytometry and fluorescence microscopy, were employed. Following treatment, cells were incubated with Fluo-3 AM solution (final concentration, 5 µM) at 37°C for 30 min. The cells were then washed twice with PBS, and the Ca²⁺-dependent fluorescence intensity was determined using a flow cytometer and CytExpert 2.0 software. Fluorescence images were visualized under a fluorescence microscope (Olympus Corporation, Tokyo, Japan) using cellSens Entry 1.17 software.

Caspase-3 activity assay

Caspase-3 activity in cells was determined using a Caspase-3 Activity Assay kit, according to the manufacturer's protocols. Luminescence was measured at 405 nm using a microplate reader (Thermo Fisher Scientific, Inc.).

Western blotting

A Mitochondria Isolation kit was used to isolate mitochondria for analysis of mitochondrial Cyt C expression, according to the manufacturer's protocol. Following treatment, cells were homogenized on ice in cell lysis buffer (RIPA buffer; Beyotime Institute of Biotechnology) containing PMSF and centrifuged at 13,500 × g for 15 min at 4°C. Subsequently, protein concentrations were determined using a BCA kit. Equal quantities of total protein (50 µg/lane) were separated by SDS-PAGE (separation gel, 15%; stacking gel, 5%) and transferred to polyvinylidene fluoride membranes. Membranes were blocked with 5% non-fat dried milk in TBS-0.1% Tween-20 at room temperature for 2 h. incubated with primary antibodies against Bax (1:1,000), Bcl-2 (1:1,000), cleaved caspase-3 (1:1,000), cleaved caspase-8 (1:1,000), cleaved caspase-9 (1:1,000), Cyt C (1:1,000), COX IV (1:2,000) and GAPDH (1:1,000) overnight at 4°C. Subsequently, membranes were incubated with horseradish peroxidas-conjugated secondary antibodies (1:50,000) at 37°C for 2 h. Protein bands were visualized using enhanced chemiluminescence (Thermo Fisher Scientific, Inc.) and the optical density of protein bands was detected using BandScan 5.0 software (Glyko, Inc.; BioMarin Pharmaceutical, Inc., Novato, CA, USA).

Statistical analysis

Data are presented as the means ± standard deviation of three independent experiments. Data were analyzed using GraphPad Prism 5.0 software (GraphPad Software, Inc., La Jolla, CA, USA). Statistical significance was evaluated by one-way analysis of variance followed by a Tukey-Kramer test for post hoc comparisons. P<0.05 was considered to indicate a statistically significant difference.

Results <sec> <title>Crocin protects osteoblasts against Dex-induced cytotoxicity and apoptosis

The viability of MC3T3-E1 osteoblasts following treatment with various concentrations of crocin was investigated to determine a nontoxic concentration range. As presented in Fig. 1B, crocin did not exhibit cytotoxic effects on osteoblasts at concentrations ≤400 µM. Subsequently, the protective effects of crocin against Dex-treated MC3T3-E1 osteoblasts were determined. As presented in Fig. 1C, the viability of osteoblasts at 24 h was increased from 59.9±1.6% following treatment with 1 µM Dex alone, to 65.1±6.7, 76.2±5.0 and 85.8±4.9% following treatment with Dex + 5, 25 and 100 µM crocin, respectively (P<0.05). There was no notable difference in cell viability following incubation for 24 or 48 h. Similarly, it was revealed that the percentage of apoptotic cells at 24 h was significantly decreased from 27.0±2.9% following incubation with 1 µM Dex alone, to 17.6±1.6, 11.6±1.4 and 8.97±0.9% following treatment with Dex + 5, 25 and 100 µM crocin, respectively (Fig. 1D; P<0.05).

Crocin protects osteoblasts against Dex-induced apoptosis by inhibiting the mitochondrial apoptotic pathway

The Δψm and expression of mitochondrial apoptotic pathway-associated proteins were investigated. As presented in Fig. 2A and B, Dex significantly reduced the Δψm (JC-1 polymer/monomer fluorescence ratio) compared with in the control group; however, crocin pretreatment reversed the effects of Dex in a dose-dependent manner. Additionally, Dex significantly increased the expression levels of cleaved caspase-9 and cleaved caspase-3 compared with in the control groups; these effects were significantly attenuated by crocin pretreatment. Conversely, Dex and crocin did not induce a significant effect on cleaved caspase-8 expression (Fig. 2C and D). Mitochondrial Cyt C levels were significantly decreased and Cyt C levels were significantly increased following Dex treatment compared with in the control group (Fig. 2E and F); crocin significantly reversed these effects. The relative expression levels of Bax and Bcl-2 exhibited similar alterations; Bax expression was increased and Bcl-2 expression was decreased by Dex, whereas these effects were reversed by crocin.

ROS and intracellular Ca2+ are involved in the protective effects of crocin on Dex-treated osteoblasts

The roles of ROS and intracellular Ca²⁺ in the protective effects of crocin on Dex-treated osteoblasts were investigated. It was demonstrated that Dex significantly increased ROS and intracellular Ca²⁺ levels compared with in the control group, whereas crocin pretreatment significantly inhibited these effects in a dose-dependent manner (Fig. 3).

Crocin induces antiapoptotic effects on Dex-treated osteoblasts via ROS/Ca2+ signaling

As presented in Fig. 4A-C, treatment with NAC or BAPTA-AM attenuated Dex-induced apoptosis, loss of the Δψm and activation of caspase-3 in osteoblasts. Furthermore, it was demonstrated that H₂O₂ and Ion attenuated the protective effects of crocin on Dex-induced apoptosis, alterations in the Δψm and caspase-3 activation (Fig. 4D-F). The results indicated that the protective effects of crocin were mediated via alterations in intracellular Ca²⁺ and ROS levels.

Association between ROS and intracellular Ca2+ in Dex- and crocin-treated osteoblasts

The association between ROS and intracellular Ca²⁺ in Dex- and crocin-treated osteoblasts was further investigated. As presented in Fig. 5A-C, NAC and BAPTA-AM significantly decreased Dex-induced ROS generation and intracellular Ca²⁺ accumulation compared with Dex treatment alone. Additionally, as presented in Fig. 5D-F, H₂O₂ and Ion treatment significantly attenuated the protective effects of crocin on Dex-induced ROS generation and intracellular Ca²⁺ accumulation. The results suggested that ROS and intracellular Ca²⁺ levels may be associated and collectively contribute to apoptosis.

Discussion

Osteoblast apoptosis remains a significant cause of GC-induced osteoporosis and ONFH (25,26). Crocin has been reported to exert antioxidative and antiapoptotic effects (27,28). Cao et al (24) revealed that crocin ameliorates ovariectomy-induced osteoporosis in rats by inhibiting oxidative stress; however, it is yet to be determined whether crocin exerts protective effects against Dex-induced osteoblast apoptosis. In the present study, it was observed that crocin significantly inhibited Dex-induced osteoblast apoptosis in a dose-dependent manner, thus suggesting that crocin may be considered a potential natural treatment for GC-induced bone diseases.

Numerous studies have reported that the antiapoptotic effects of crocin protect various tissues and organs (19,29–31), whereas others have observed that its proapoptotic effects promote apoptosis in tumor cells (32–34). Therefore, crocin appears to exhibit antiapoptotic and proapoptotic properties; however, the dose ranges of crocin used in these studies may be responsible for these varied effects, as doses <500 µM tend to induce antiapoptotic effects, whereas those >500 µM induce proapoptotic effects. The present findings were similar; concentrations ≤400 µM did not exhibit toxicity, whereas those >1,000 µM significantly reduced osteoblast viability.

To identify the mechanisms underlying the antiapoptotic effects of crocin on Dex-induced apoptosis of osteoblasts, the mitochondrial apoptotic pathway was investigated. The results revealed that Dex exposure decreased the Δψm, whereas crocin treatment reversed this effect in a dose-dependent manner. In addition, Dex activated caspase-9, but did not alter caspase-8 activity, suggesting that the mitochondrial pathway, but not the death receptor-mediated pathway, contributed to Dex-induced osteoblast apoptosis. These results were consistent with the findings of Li et al (35). Furthermore, it was demonstrated that crocin treatment attenuated Dex-induced caspase-9 activation, suggesting that crocin inhibited the mitochondrial apoptotic pathway. Loss of the Δψm is associated with release of Cyt C from the mitochondria to the cytosol, subsequently leading to the activation of caspase-3 and apoptosis (36). A decrease in the Bcl-2/Bax ratio can induce loss of the Δψm (37,38). Consistent with these findings, the results of the present study indicated that Cyt C translocated from the mitochondria to the cytosol following Dex treatment, and that crocin attenuated this effect. The expression levels of Bcl-2, Bax and cleaved caspase-3 in the present study also supported the hypothesis that crocin may suppress the mitochondrial apoptosis pathway in Dex-treated osteoblasts.

ROS, which are primarily generated in the mitochondria, induce loss of the Δψm and serve an important role in osteoblast apoptosis (11,39). Almeida et al (13) observed elevated ROS levels and increased apoptosis in Dex-treated UAMS-32 osteoblasts; however, these effects are inhibited by the antioxidant NAC. The present study also revealed that ROS was involved in Dex-induced osteoblast apoptosis, and that crocin attenuated ROS generation. Inhibition of ROS with NAC suppressed Dex-induced apoptosis. Furthermore, H₂O₂ suppressed the antiapoptotic effects of crocin on Dex-treated osteoblasts. Intracellular Ca²⁺ overload has also been reported to lead to loss of the Δψm and the induction of apoptosis (40,41). Pretreatment with the calcium chelator BAPTA-AM partially suppresses apoptosis (42). Similarly, it was observed in the present study that Dex increased intracellular Ca²⁺ concentrations, and that crocin reversed the effect. Notably, BAPTA-AM also suppressed Dex-induced apoptosis, whereas the calcium ionophore Ion reversed the antiapoptotic effects of crocin on Dex-treated osteoblasts. Zhang et al (43) reported that NAC and BAPTA-AM suppress the eicosapentaenoic acid-induced apoptosis of HepG2 cells, and suggested the involvement of the ROS-Ca²⁺-JNK mitochondrial pathways. Based on the present findings, it was hypothesized that crocin may induce antiapoptotic effects on Dex-induced osteoblasts by inhibiting the ROS/Ca²⁺-mediated mitochondrial pathway.

The results of the present study suggested that ROS and intracellular Ca²⁺ levels are associated in Dex-treated cells or Dex- and crocin-treated cells. Notably, treatment with H₂O₂ or NAC also affected intracellular Ca²⁺ levels, whereas treatment with Ion or BAPTA-AM also affected ROS levels. Furthermore, a number of studies have reported that ROS contributes to intracellular Ca²⁺ overload (16,44), and other studies have demonstrated that intracellular Ca²⁺ overload leads to increased ROS production (45,46). Wang et al (44) suggested that oxidative stress decreases the efficiency of ATPase, thus contributing to voltage-gated calcium ion influx and subsequently apoptosis. Lipton and Nicotera (45) suggested that cytosolic Ca²⁺ overload leads to depolarization of the mitochondria, subsequently contributing to the accumulation of ROS; however, the potential mechanisms are complex and requires further investigation.

In conclusion, crocin exerted protective effects against apoptosis in Dex-induced MC3T3-E1 osteoblasts. Inactivation of the ROS/Ca²⁺-mediated mitochondrial pathway may be involved in the inhibitory effects of crocin on osteoblast apoptosis. The present study may promote further investigation into the application of crocin as a treatment for GC-induced osteoporosis and ONFH.

Acknowledgements

Not applicable.

Funding

The present study was supported by a grant from the National Natural Science Foundation of China (grant no. 81672154).

Availability of data and materials

All data generated and/or analyzed during this study are included in this published article.

Author's contributions

ZN, SD and HP designed the study. ZN, SD, LZ, QL and SC performed the experiments. ZN, SD and LZ performed data analysis. ZN drafted the manuscript. ZN, SD, LZ and HP revised the manuscript. All authors reviewed the manuscript.

Ethics approval and consent to participate

Not applicable.

Patient consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

References 1

Deng

Dai

Chen

Nie

Zhou

Fang

Peng

Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway

Bio Pharmacother1106026082019

10.1016/j.biopha.2018.11.103

Feng

Zheng

Tang

Cheng

Pan

Fludarabine inhibits STAT1-mediated up-regulation of caspase-3 expression in dexamethasone-induced osteoblasts apoptosis and slows the progression of steroid-induced avascular necrosis of the femoral head in rats

Apoptosis22100110122017

10.1007/s10495-017-1383-1

28601953

Weinstein

Jilka

Parfitt

Manolagas

Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone

J Clin Invest1022742821998

10.1172/JCI2799

9664068

508885

Zalavras

Shah

Birnbaum

Frenkel

Role of apoptosis in glucocorticoid-induced osteoporosis and osteonecrosis

Crit Rev Eukaryot Gene Expr132212352003

10.1615/CritRevEukaryotGeneExpr.v13.i24.140

14696969

Kerachian

Séguin

Harvey

Glucocorticoids in osteonecrosis of the femoral head: A new understanding of the mechanisms of action

J Steroid Biochem Mol Biol1141211282009

10.1016/j.jsbmb.2009.02.007

19429441

Chen

Zhang

OuYang

Guan

Liu

Glucocorticoid induced osteoblast apoptosis by increasing E4BP4 expression via up-regulation of Bim

Calcif Tissue Int946406472014

10.1007/s00223-014-9847-6

24658772

Chen

Peng

Zhou

Fang

Administration of erythropoietin exerts protective effects against glucocorticoid-induced osteonecrosis of the femoral head in rats

Int J Mol Med338408482014

10.3892/ijmm.2014.1644

24503957

3976124

Zheng

Yang

Peng

Chen

Zhou

Fang

Qiu

Wang

Gastrodin prevents steroid-induced osteonecrosis of the femoral head in rats by anti-apoptosis

Chin Med J (Engl)127392639312014

25421192

Dai

Mao

Sun

Muhammad

Zhang

Zhou

Huang

Attenuation of oxidative stress-induced osteoblast apoptosis by curcumin is associated with preservation of mitochondrial functions and increased Akt-GSK3β signaling

Cell Physiol Biochem416616772017

10.1159/000457945

28291961

Linares

Xing

Govoni

Chen

Mohan

Glutaredoxin 5 regulates osteoblast apoptosis by protecting against oxidative stress

Bone447958042009

10.1016/j.bone.2009.01.003

19442627

4683083

Han

Guan

Zhang

Bai

Aluminum induces osteoblast apoptosis through the oxidative stress-mediated JNK signaling pathway

Biol Trace Elem Res1505025082012

10.1007/s12011-012-9523-5

23065425

Ding

Zhao

Jiang

Allicin inhibits oxidative stress-induced mitochondrial dysfunction and apoptosis by promoting PI3K/AKT and CREB/ERK signaling in osteoblast cells

Exp Ther Med11255325602016

10.3892/etm.2016.3179

27284348

4887917

Almeida

Han

Ambrogini

Weinstein

Manolagas

Glucocorticoids and tumor necrosis factor alpha increase oxidative stress and suppress Wnt protein signaling in osteoblasts

J Biol Chem28644326443352011

10.1074/jbc.M111.283481

22030390

3247937

Tan

Liu

Geng

Liu

Tong

Tang

Qiu

Heat stress induces apoptosis through a Ca²⁺-mediated mitochondrial apoptotic pathway in human umbilical vein endothelial cells

PLoS One9e1110832014

10.1371/journal.pone.0111083

25549352

4280109

Wang

Xia

Nie

Zhou

Zhang

Niu

Hou

Cao

Musca domestica larva lectin induces apoptosis in BEL-7402 cells through a Ca(2+)/JNK-mediated mitochondrial pathway

Cell Biochem Biophys663193292013

10.1007/s12013-012-9489-0

23247835

Nam

Jung

Yoo

Ahn

Suh

H₂O₂ enhances Ca²⁺ release from osteoblast internal stores

Yonsei Med J432292352002

10.3349/ymj.2002.43.2.229

11971217

Hoshyar

Mollaei

A comprehensive review on anticancer mechanisms of the main carotenoid of saffron, crocin

J Pharm Pharmacol69141914272017

10.1111/jphp.12776

28675431

Yarijani

Pourmotabbed

Najafi

Crocin has anti-inflammatory and protective effects in ischemia-reperfusion induced renal injuries

Iran J Basic Med Sci207537592017

28852439

5569594

Ben Salem

Boussabbeh

Kantaoui

Bacha

Abid-Essefi

Crocin, the main active saffron constituent, mitigates dichlorvos-induced oxidative stress and apoptosis in HCT-116 cells

Biomed Pharmacother8265712016

10.1016/j.biopha.2016.04.063

27470340

Yang

Huo

Liu

Chen

Zhu

Crocin inhibits oxidative stress and pro-inflammatory response of microglial cells associated with diabetic retinopathy through the activation of PI3K/Akt signaling pathway

J Mol Neurosci615815892017

10.1007/s12031-017-0899-8

28238066

Santhosh

Sundaram

Sunitha

Jnaneshwari

Devaraja

Kemparaju

Girish

Propensity of crocin to offset Vipera russelli venom induced oxidative stress mediated neutrophil apoptosis: A biochemical insight

Cytotechnology6873852016

10.1007/s10616-014-9752-x

25149285

Oruc

Gönül

Tunay

Oruc

Bozkurt

Karavelioğlu

Bağcıoğlu

Coşkun

Celik

The antioxidant and antiapoptotic effects of crocin pretreatment on global cerebral ischemia reperfusion injury induced by four vessels occlusion in rats

Life Sci15479862016

10.1016/j.lfs.2016.04.028

27117584

Liu

Chu

Wang

Zhang

Guo

Liu

Dong

Liu

Crocin, a carotenoid component of Crocus cativus, exerts inhibitory effects on L-type Ca(2+) current, Ca(2+) transient, and contractility in rat ventricular myocytes

Can J Physiol Pharmacol943023082016

10.1139/cjpp-2015-0214

26674933

Cao

Xiao

Yan

Zhao

Liu

Feng

Zhang

Wang

Feng

Lei

Preventive effect of crocin on osteoporosis in an ovariectomized rat model

Evid Based Complement Alternat Med20148251812014

10.1155/2014/825181

25202337

4150429

Zhang

Jin

Yan

MicroRNA206 contributes to the progression of steroidinduced avascular necrosis of the femoral head by inducing osteoblast apoptosis by suppressing programmed cell death 4

Mol Med Rep178018082018

29115490

Yun

Yoon

Jeong

Chung

Glucocorticoid induces apoptosis of osteoblast cells through the activation of glycogen synthase kinase 3beta

J Bone Miner Metab271401482009

10.1007/s00774-008-0019-5

19066717

Dianat

Radan

Badavi

Mard

Bayati

Ahmadizadeh

Crocin attenuates cigarette smoke-induced lung injury and cardiac dysfunction by anti-oxidative effects: The role of Nrf2 antioxidant system in preventing oxidative stress

Respir Res19582018

10.1186/s12931-018-0766-3

29631592

5891913

Razavi

Hosseinzadeh

Abnous

Khoei

Imenshahidi

Protective effect of crocin against apoptosis induced by subchronic exposure of the rat vascular system to diazinon

Toxicol Ind Health32123712452016

10.1177/0748233714554941

27353299

Yousefsani

Mehri

Pourahmad

Hosseinzadeh

Crocin prevents sub-cellular organelle damage, proteolysis apoptosis in rat hepatocytes

A justification for its hepatoprotection

Iran J Pharm Res175535622018

29881413

5985173

Boussabbeh

Prola

Ben Salem

Guilbert

Bacha

Lemaire

Abis-Essefi

Crocin and quercetin prevent PAT-induced apoptosis in mammalian cells: Involvement of ROS-mediated ER stress pathway

Environ Toxicol31185118582016

10.1002/tox.22185

26314699

Thushara

Hemshekhar

Santhosh

Jnaneshwari

Nayaka

Naveen

Kemparaju

Girish

Crocin, a dietary additive protects platelets from oxidative stress-induced apoptosis and inhibits platelet aggregation

Mol Cell Biochem37373832013

10.1007/s11010-012-1476-7

23065381

Amin

Bajbouj

Koch

Gandesiri

Schneider-Stock

Defective autophagosome formation in p53-null colorectal cancer reinforces crocin-induced apoptosis

Int J Mol Sci16154415612015

10.3390/ijms16011544

25584615

4307319

Rezaee

Jamialahmadi

Riahi Zanjani

Mahmoudi

Abnous

Zamani Taghizadeh Rabe

Tabasi

Zali

Rezaee

Amin

Karimi

Crocin effects on human myeloma cells regarding intracellular redox state, DNA fragmentation, and apoptosis or necrosis profile

Jundishapur J Nat Pharm Prod9e201312014

10.17795/jjnpp-20131

25625054

4302399

Hoshyar

Bathaie

Sadeghizadeh

Crocin triggers the apoptosis through increasing the Bax/Bcl-2 ratio and caspase activation in human gastric adenocarcinoma, AGS, cells

DNA Cell Biol3250572013

10.1089/dna.2012.1866

23347444

Tong

Zou

Zhang

Tanshinone IIA blocks dexamethasone-induced apoptosis in osteoblasts through inhibiting Nox4-derived ROS production

Int J Clin Exp Pathol813695137062015

26722597

4680542

Bak

Kim

Park

Han

Kim

Neuroprotective effects of 20(S)-protopanaxadiol against glutamate-induced mitochondrial dysfunction in PC12 cells

Int J Mol Med373783862016

10.3892/ijmm.2015.2440

26709399

Ding

Wang

Mao

Shi

Allicin protects against H₂O₂-induced apoptosis of PC12 cells via the mitochondrial pathway

Exp Ther Med14205320592017

10.3892/etm.2017.4725

28962124

5609123

Giménez-Cassina

Danial

Regulation of mitochondrial nutrient and energy metabolism by BCL-2 family proteins

Trends Endocrinol Metab261651752015

10.1016/j.tem.2015.02.004

25748272

4380665

Gan

Huang

Yan

Blockade of Drp1 rescues oxidative stress-induced osteoblast dysfunction

Biochem Biophys Res Commun4687197252015

10.1016/j.bbrc.2015.11.022

26577411

4834976

Assaf

Azouri

Pallardy

Ochratoxin A induces apoptosis in human lymphocytes through down regulation of Bcl-xL

Toxicol Sci793353442004

10.1093/toxsci/kfh123

15056805

Liu

Wang

The nitric oxide prodrug JS-K induces Ca(2+)-mediated apoptosis in human hepatocellular carcinoma HepG2 cells

J Biochem Mol Toxicol301921992016

10.1002/jbt.21778

26616367

Wang

Zhu

Liu

Oxidative stress and Ca(2+) signals involved on cadmium-induced apoptosis in rat hepatocyte

Biol Trace Elem Res1611801892014

10.1007/s12011-014-0105-6

25123461

Zhang

Han

Cheng

Hou

Cao

Wang

Eicosapentaenoic acid (EPA) induced apoptosis in HepG2 cells through ROS-Ca(2+)-JNK mitochondrial pathways

Biochem Biophys Res Commun4569269322015

10.1016/j.bbrc.2014.12.036

25529445

Wang

Zheng

Wang

Chen

Tanshinone IIA attenuates neuronal damage and the impairment of long-term potentiation induced by hydrogen peroxide

J Ethnopharmacol1341471552011

10.1016/j.jep.2010.11.069

21134432

Lipton

Nicotera

Calcium, free radicals and excitotoxins in neuronal apoptosis

Cell Calcium231651711998

10.1016/S0143-4160(98)90115-4

9601612

Chen

Gao

Yang

Guo

Wang

Zhang

Zhou

Yao

Inhibition of VDAC1 prevents Ca²⁺-mediated oxidative stress and apoptosis induced by 5-aminolevulinic acid mediated sonodynamic therapy in THP-1 macrophages

Apoptosis19171217262014

10.1007/s10495-014-1045-5

25342393

Figure 1.

Effects of Cro on the viability and apoptosis of Dex-treated MC3T3-E1 osteoblasts. (A) Molecular structure of Cro. (B) Cell viability was examined to detect the nontoxic concentrations of Cro using an MTT assay. MC3T3-E1 osteoblasts were incubated with Cro (5, 25, 100, 400, 1,000, and 4,000 µM) for 24 and 48 h, as determined by an MTT assay. (C) Viability of osteoblasts pretreated with Cro (5, 25 and 100 µM) for 1 h and then treated with 1 µM Dex for 24 and 48 h, as determined by an MTT assay. (D) Apoptosis of osteoblasts pretreated with Cro (5, 25 and 100 µM) for 1 h and then treated with 1 µM Dex for 24 h, as determined by flow cytometry using an Annexin V-FITC/PI kit. (E) Quantitative analysis of apoptotic cells. Data are presented as the means ± standard deviation of three independent experiments. **P<0.01 and ***P<0.001 vs. Ctrl; ^#P<0.05, ^###P<0.001 vs. Dex. Cro, crocin; Ctrl, control; Dex, dexamethasone; FITC, fluorescein isothiocyanate; PI, propidium iodide.

Figure 2.

Effects of Cro on the mitochondrial apoptotic pathway in Dex-treated MC3T3-E1 osteoblasts. Cells were pretreated with Cro (5, 25 and 100 µM) for 1 h and were then treated with 1 µM Dex for 24 h. (A) Δψm of osteoblasts, as determined using a JC-1 Assay kit. (B) Quantitative analysis of the Δψm, as determined by calculating the JC-1 polymer/monomer fluorescence ratio. (C) Western blot analysis of cleaved caspase-9, cleaved caspase-8 and cleaved caspase-3 protein expression. (D) Semi-quantitative analysis of the protein expression levels of cleaved caspase-9, cleaved caspase-8 and cleaved caspase-3. (E) Western blot analysis and semi-quantitative analysis of Bcl-2 and Bax protein expression. (F) Western blot analysis and semi-quantitative analysis of Mito Cyt C protein expression. (G) Western blot analysis and semi-quantitative analysis of Cyto Cyt C protein expression. Data are presented as the means ± standard deviation of three independent experiments. ***P<0.001 vs. Ctrl; ^#P<0.05, ^##P<0.01 and ^###P<0.001 vs. Dex. Δψm, mitochondrial transmembrane potential; Bcl-2, B-cell lymphoma-2; Bax, Bcl-2-associated X protein; Cro, crocin; Ctrl, control; Cyt C, cytochrome c; COX IV, Cyt C oxidase IV; Cyto, cytosolic; Dex, dexamethasone; Mito, mitochondrial.

Figure 3.

Effects of Cro on ROS and intracellular Ca²⁺ levels in Dex-treated MC3T3-E1 osteoblasts. Cells were pretreated with Cro (5, 25 and 100 µM) for 1 h and were then treated with 1 µM Dex for 24 h. (A) ROS levels, as determined by flow cytometry. (B) Quantitative analysis of ROS. (C) Intracellular Ca²⁺ levels, as determined by flow cytometry. (D) Quantitative analysis of intracellular Ca²⁺ levels. Data are presented as the means ± standard deviation of three independent experiments. ***P<0.001 vs. Ctrl; ^###P<0.001 vs. Dex. Cro, crocin; DCFH-DA, dichlorodihydrofluorescein diacetate; Dex, dexamethasone; ROS, reactive oxygen species.

Figure 4.

Effects of ROS and Ca²⁺ signaling on Dex- and Cro-treated MC3T3-E1 osteoblasts. Cells were pretreated with 100 µM Cro, 2 mM NAC, 20 µM BAP, 100 µM H₂O₂ or 0.5 µM Ion for 1 h prior to treatment with 1 µM Dex for 24 h. Effects of NAC and BAP on Dex-induced (A) Δψm loss, (B) caspase-3 activation and (C) apoptosis of osteoblasts. Effects of H₂O₂ and Ion on the protective effects of Cro against Dex-induced (D) loss of the Δψm, (E) caspase-3 activation and (F) apoptosis. Data are presented as the means ± standard deviation of three independent experiments. ***P<0.001 vs. control; ^#P<0.05, ^##P<0.01 and ^###P<0.001 vs. Dex; ^&P<0.05, ^&&P<0.01 and ^&&&P<0.001 vs. Dex + Cro. Δψm, mitochondrial transmembrane potential; BAP, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; Cro, crocin; Dex, dexamethasone; Ion, ionomycin; NAC, N-acetyl-L-cysteine.

Figure 5.

Association between ROS and intracellular Ca²⁺ in Dex- and Cro-treated MC3T3-E1 osteoblasts. Cells were pretreated with 100 µM Cro, 2 mM NAC, 20 µM BAP, 100 µM H₂O₂ or 0.5 µM Ion for 1 h prior to treatment with 1 µM Dex for 24 h. (A) Visualization of ROS generation and intracellular Ca²⁺ by fluorescence microscopy (magnification, ×100). Quantitative analysis of (B) ROS production and (C) intracellular Ca²⁺ levels following pretreatment with NAC or BAP, and treatment with Dex, as determined via flow cytometry. (D) Visualization of ROS generation and intracellular Ca²⁺ by fluorescence microscopy (magnification, ×100). Quantitative analysis of (E) ROS production and (F) intracellular Ca²⁺ levels following pretreatment with Cro with or without H₂O₂ and Ion, and treatment with Dex, as determined via flow cytometry. Data are presented as the means ± standard deviation of three independent experiments. ***P<0.001 vs. Ctrl; ^###P<0.001 vs. Dex; ^&&&P<0.001 vs. Dex + Cro. BAP, 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid; Cro, crocin; Dex, dexamethasone; Ion, ionomycin; NAC, N-acetyl-L-cysteine; ROS, reactive oxygen species.